| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/07/2003 | US20030148360 Comprises immobilized nucleic acids/ligands; optical fibers |
| 08/07/2003 | US20030148358 Detecting benign prostatic hyperplasia by assaying prostate tissue to determine amount of Breast Tumor Kinases (BRK/Sik) present |
| 08/07/2003 | US20030148356 Amyloid precursor protein (APP); secretases |
| 08/07/2003 | US20030148354 Devices and methods for isolating and detecting specific substances in complex matrices |
| 08/07/2003 | US20030148350 Blot analysis; electrophoresis; estimating life expectancy |
| 08/07/2003 | US20030148349 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme |
| 08/07/2003 | US20030148348 Self-replicating RNA molecule from hepatitis C virus |
| 08/07/2003 | US20030148346 Comprises Staphylococcus aureus virulence genes which target bactericides in assay; drug screening; vaccines |
| 08/07/2003 | US20030148345 Methods for evaluating drug-resistance gene expression in the cancer patient |
| 08/07/2003 | US20030148344 Annealing primer and single-stranded template, combining with polymerase, then adding nucleotide triphosphate; optical fibers; semiconductors; eliminates cloning |
| 08/07/2003 | US20030148343 Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids |
| 08/07/2003 | US20030148341 Gene amplification and overexpression in cancer |
| 08/07/2003 | US20030148339 Artificial genes for use as controls in gene expression analysis systems |
| 08/07/2003 | US20030148336 Polymorphic marker that can be used to assess the efficacy of interferon therapy |
| 08/07/2003 | US20030148335 Detecting targets by unique identifier nucleotide tags |
| 08/07/2003 | US20030148334 Differentially-expressed genes and polypeptides in angiogenesis |
| 08/07/2003 | US20030148332 Adaptive baseline algorithm for quantitative PCR |
| 08/07/2003 | US20030148328 Which are coupled to electrodes via conductive oligomers for detection of hybridization; site directed mutagenesis |
| 08/07/2003 | US20030148327 Nucleic acid of given sequence; oligonucleotides and oligomers for detecting the cytosine methylation of genes; tumors and cancer |
| 08/07/2003 | US20030148326 Diagnosis of diseases associated with dna transcription |
| 08/07/2003 | US20030148323 Analyzing nucleic acid and determining presence of mutant alleles encoding a protein with reduced activity/thermal stability; useful in diagnosing schizophrenia |
| 08/07/2003 | US20030148322 Control of TGFbeta signaling by km23 superfamily members |
| 08/07/2003 | US20030148321 Detecting heparanase expression in cells at the gene, protein and/or enzyme activity levels; useful in distinguishing between different types of differentiated and/or undifferentiated lymphomas and leukemias |
| 08/07/2003 | US20030148316 Methods and compositions relating to plasmacytoid dendritic cells |
| 08/07/2003 | US20030148315 Increases complementarity in a heteroduplex polynucleotide sequence |
| 08/07/2003 | US20030148314 Isolated nucleic acid of given sequence; diagnosis by measuring level of expression of marker proteins |
| 08/07/2003 | US20030148313 Applications of parallel genomic analysis |
| 08/07/2003 | US20030148311 Aspartate carbamyltransferase as herbicidal target |
| 08/07/2003 | US20030148310 Incubating; signal generated after dissociation; increased intensity; does not require cleavage |
| 08/07/2003 | US20030148309 For enhanced recombinogenicity, genome copy number, and capacity for expression and/or secretion of proteins and secondary metabolites |
| 08/07/2003 | US20030148308 Target molecule attachment to surfaces |
| 08/07/2003 | US20030148307 Method and kit for detecting resistance to antiviral drugs |
| 08/07/2003 | US20030148306 Aggrecanase molecules |
| 08/07/2003 | US20030148303 Hybridizing to the target sequence a signal primer comprising a reporter probe; quenching; fluorescence |
| 08/07/2003 | US20030148302 Polymerase chain reaction (PCR); quantitating the presence of nucleic acid sequences by evaluation of amplification data; identifying threshold based upon exponential and baseline regions |
| 08/07/2003 | US20030148301 Applying a primer with DNA polymerase to a chromosome and determining if elongation has taken place; use in diagnosing hereditary diseases |
| 08/07/2003 | US20030148299 Linearizing with restriction enzymes; ligating nucleotide sequence; transforming bacterial cells and selecting for colonies based on expression of the reporter molecule |
| 08/07/2003 | US20030148298 Comparing level of expression of a marker in a sample from the subject; corresponds to a transcribed nucleotide |
| 08/07/2003 | US20030148296 Drug screenig; administering compound and testing tissue for uncoupling protein 1, cytosolic malic enzyme and atrial natriuretic factor |
| 08/07/2003 | US20030148295 Endothelial cells; nucleotide sequences; microarrays; algorithms |
| 08/07/2003 | US20030148293 Mutation analysis by PCR and mass spectrometry |
| 08/07/2003 | US20030148292 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 08/07/2003 | US20030148291 Method of immobilizing biologically active molecules for assay purposes in a microfluidic format |
| 08/07/2003 | US20030148290 By providing a means of detecting nucleotides, that are characteristic for methylated sites after bisulfite treatment of the genomic DNA; uses labels and detection of fluorescence resonance energy transfer (FRET) of amplified sample DNA |
| 08/07/2003 | US20030148289 Modification of markers such as nanotubes form nanotube assemblies that are easily detected using a number of surface analysis devices such as atomic force microscopy |
| 08/07/2003 | US20030148288 Tumor necrosis factor (TNF); by use of a minor groove binder and shorter hybridization probes so that polymorphisms of only a single nucleotide, may be detected; diagnostic kits; septic shock, multiple sclerosis, rheumatoid arthritis |
| 08/07/2003 | US20030148287 Libraries and kits for detecting transcription factor activity |
| 08/07/2003 | US20030148286 Ribosomal RNA (rRNA)-derived cDNA used as an internal standard or control to achieve normalization of hybridization signal detection in microarray biochip technology |
| 08/07/2003 | US20030148284 Solid phase detection of nucleic acid molecules |
| 08/07/2003 | US20030148283 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions |
| 08/07/2003 | US20030148282 For detecting a nucleic acid; detectable change (preferably a color change) is brought about as a result of the hybridization of the nanoparticle-conjugated oligonucleotide to the nucleic acid; probes |
| 08/07/2003 | US20030148280 Oligonucleotide primer sets, probes; kits; detecting in test sample Human Immunodeficiency Virus Type 1 (HIV-1) |
| 08/07/2003 | US20030148279 Nucleic acid probe unique to methanogenic bacteria; detection of methanogenic bacteria has use such as to stimulate production of methane from unrecoverable petroleum crude oils in hydrocarbon formations |
| 08/07/2003 | US20030148278 Test kit and method for quantitatively detecting genetically modified DNA in foodstuff by means of fluorescence-coupled PCR |
| 08/07/2003 | US20030148276 Method for identification, separation and quantitative measurement of nucleic acid fragments |
| 08/07/2003 | US20030148274 Identification of neural defects associated with the nucleosomal assembly protein 112 gene |
| 08/07/2003 | US20030148273 Target enrichment and amplification |
| 08/07/2003 | US20030148271 Given amino acid sequence; expression vectors, host cells; diagnosis, prevention and treatment of diseases associated with expression of the kallikrein |
| 08/07/2003 | US20030148270 Genes from the 20q13 amplicon and their uses |
| 08/07/2003 | US20030148269 Centrifugally-enhanced method of determining ligand/target affinity |
| 08/07/2003 | US20030148268 By identifying bacterial cell wall substrates that bind the binding domain of bacteriophage lysins |
| 08/07/2003 | US20030148267 Identifying compounds that increase the mutation rate of hepatitis C virus; method based on in vitro cell-based system for inducing HCV replication and producing hepatitis C nucleic acids |
| 08/07/2003 | US20030148266 Use in diagnostic methods and as immunogens |
| 08/07/2003 | US20030148264 PDZ (PSD-95/Discs large/ZO-I) domains, (PSD-95 = post-synaptic density protein-95); PDZ proteins involved in assembling ion channels and other transmembrane receptors, at specialized subcellular sites such as tight junctions |
| 08/07/2003 | US20030148263 Phage display; selection of ligands that bind to a cell surface receptor/moeity and internalize useful in delivery of molecules to the nucleus of a target cell; rolling circle amplification |
| 08/07/2003 | US20030148257 In situ screening to optimize variables in organic reactions |
| 08/07/2003 | US20030148169 Biosensor carrying redox enzymes |
| 08/07/2003 | US20030147924 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/07/2003 | US20030147909 Protein naturally obtained through the activation of the immune system of fish inoculated with the pathogen; for aquaculture |
| 08/07/2003 | US20030147903 ABC transport polynucleotides, polypeptides and antibodies |
| 08/07/2003 | US20030147893 Novel human transmembrane 4 superfamily protein |
| 08/07/2003 | US20030147887 B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies |
| 08/07/2003 | US20030147883 Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection |
| 08/07/2003 | US20030147875 Sulfatases and methods of use thereof |
| 08/07/2003 | US20030147870 Administering an immunostimulatory nucleic acid molecule to increase an antigen-specific lymphocyte, chemokine for blocking HIV infections |
| 08/07/2003 | US20030147866 Novel BGP compounds for therapy and diagnosis and methods for using same |
| 08/07/2003 | US20030147858 Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders |
| 08/07/2003 | US20030147856 Proteins |
| 08/07/2003 | US20030147847 Isolated nucleic acid encoding a protein comprising a glycosylphosphatidyl inositol-1 polypeptide can enhance the cytolytic activity of peripheral blood mononuclear cells |
| 08/07/2003 | US20030147810 Compositions and methods for reporting of protease activity within the secretory pathway |
| 08/07/2003 | US20030146922 System and method for diminished reality |
| 08/07/2003 | US20030146155 Nucleic acid pattern purification; rotating disks; thermocycles; isolating plasmids |
| 08/07/2003 | US20030146145 Mesoporous permeation layers for use on active electronic matrix devices |
| 08/07/2003 | US20030146113 Electrochemical sensor for determining blood clotting, corresponding system for measuring blood clotting and method for determining blood clotting |
| 08/07/2003 | US20030146111 Enzymatic-electrochemical measuring device |
| 08/07/2003 | US20030146110 Determination glucose concentration in blood |
| 08/07/2003 | US20030146097 Buffers for electrophoresis and use thereof |
| 08/07/2003 | US20030146095 Methods for the electronic, Homogeneous assembly and fabrication of devices |
| 08/07/2003 | CA2849427A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/07/2003 | CA2474982A1 Computer systems and methods for identifying genes and determining pathways associated with traits |
| 08/07/2003 | CA2474908A1 Aggrecanase molecules |
| 08/07/2003 | CA2474866A1 Lid element |
| 08/07/2003 | CA2474864A1 Methods and means for amplifying nucleic acid |
| 08/07/2003 | CA2474860A1 Methods for identifying polyadenylation sites and genes thereof |
| 08/07/2003 | CA2474855A1 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof |
| 08/07/2003 | CA2474759A1 Gene for peripheral arterial occlusive disease |
| 08/07/2003 | CA2474724A1 Process for detecting predisposition to a cardiovascular disease |
| 08/07/2003 | CA2474689A1 Drugs ameliorating circadian rhythum disorder |
| 08/07/2003 | CA2474659A1 Nucleic acid fragments for the identification of dechlorinating bacteria |
| 08/07/2003 | CA2474649A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |